150 related articles for article (PubMed ID: 1003541)
21. Leukocyte migration in ovarian carcinoma: comparison of inhibitory activity of tumor extracts.
Faiferman I; Gleicher N; Cohen CJ; Koffler D
J Natl Cancer Inst; 1977 Dec; 59(6):1593-7. PubMed ID: 200754
[TBL] [Abstract][Full Text] [Related]
22. Leukocyte adherence inhibition assay in human pulmonary neoplasia.
Kotlar HK; Eker P; Brennhovd I; Høst H; Høie J; Sanner T
Eur J Cancer Clin Oncol; 1982 Feb; 18(2):141-6. PubMed ID: 7047165
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of leukocyte migration with melanoma-associated antigens in choroidal tumors.
Char DH
Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):176-9. PubMed ID: 832980
[TBL] [Abstract][Full Text] [Related]
24. Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigen.
McCoy JL; Dean JH; Cannon GB; Jerome LJ; Alford TC; Parks WP; Gilden RV; Oroszlan ST; Herberman RB
J Natl Cancer Inst; 1978 Jun; 60(6):1259-67. PubMed ID: 206704
[No Abstract] [Full Text] [Related]
25. Breast cancer skin test antigens of increased sensitivity prepared from vesicular stomatitis virus-infected tumor cells.
Austin FC; Boone CW; Levin DL; Cavins JA; Djerassi I; Rosner D; Case R; Klein E
Cancer; 1982 May; 49(10):2034-42. PubMed ID: 6280832
[TBL] [Abstract][Full Text] [Related]
26. The leukocyte migration inhibition response to certain breast cancer-related antigens (MCF-7 and MuMTV): their potential as discriminants.
Wanebo HJ; Fukuda M; Tsuei L; Sarkar N; Ashikari H
Surgery; 1979 Aug; 86(2):275-83. PubMed ID: 462374
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
28. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
29. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
Cochran AJ; Spilg WG; Mackie RM; Thomas CE
Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human leukocyte migration in agarose by kcl extracts of carcinoma of the lung.
Boddie AW; Holmes EC; Roth JA; Morton DL
Int J Cancer; 1975 May; 15(5):823-9. PubMed ID: 1140874
[TBL] [Abstract][Full Text] [Related]
31. Leukocyte migration inhibition in human pulmonary neoplasia.
Vose BM; Kimber I; Moore M
J Natl Cancer Inst; 1977 Mar; 58(3):483-8. PubMed ID: 839553
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
Lee C; Chen S; Lin T
Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
[TBL] [Abstract][Full Text] [Related]
33. Assessment of cellular immune response to cancer of the breast.
Herberman RB
Ann Clin Lab Sci; 1979; 9(6):467-73. PubMed ID: 229763
[TBL] [Abstract][Full Text] [Related]
34. Leukocyte migration inhibition of tumor antigen and purified protein derivative reactivity in guinea pigs sensitized to line 10 hepatocarcinoma and BCG.
McCoy JL; Brandhorst J; Hanna MG
J Natl Cancer Inst; 1978 Mar; 60(3):693-9. PubMed ID: 75270
[TBL] [Abstract][Full Text] [Related]
35. Leukocyte migration inhibition assay in patients with prostate adenocarcinoma.
Wright GL; Schellhammer PF; Faulconer RJ; Reid JW; Brassil DN; Sieg SM
Prostate; 1981; 2(2):121-31. PubMed ID: 6170963
[TBL] [Abstract][Full Text] [Related]
36. In vitro detection of cellular immunity to melanoma antigens in man by the monocyte spreading inhibition test.
Mazuran R; Mujagic H; Malenica B; Silobrcic V
Int J Cancer; 1976 Jan; 17(1):14-20. PubMed ID: 1248899
[TBL] [Abstract][Full Text] [Related]
37. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
38. Leukocyte migration inhibition assay in patients with bladder cancer.
Schellhammer PF; Wright GL; Rosato FE; Faulconer RJ
J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
[TBL] [Abstract][Full Text] [Related]
39. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
[No Abstract] [Full Text] [Related]
40. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
